Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1025269.RAkUVFYjnEj4PZRKYLNX1GZlb3xEggkF2T6_tk2DeDqBM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1025269.RAkUVFYjnEj4PZRKYLNX1GZlb3xEggkF2T6_tk2DeDqBM130_assertion type Assertion NP1025269.RAkUVFYjnEj4PZRKYLNX1GZlb3xEggkF2T6_tk2DeDqBM130_head.
- NP1025269.RAkUVFYjnEj4PZRKYLNX1GZlb3xEggkF2T6_tk2DeDqBM130_assertion wasGeneratedBy ECO_0000203 NP1025269.RAkUVFYjnEj4PZRKYLNX1GZlb3xEggkF2T6_tk2DeDqBM130_provenance.
- NP1025269.RAkUVFYjnEj4PZRKYLNX1GZlb3xEggkF2T6_tk2DeDqBM130_assertion wasDerivedFrom befree-2016 NP1025269.RAkUVFYjnEj4PZRKYLNX1GZlb3xEggkF2T6_tk2DeDqBM130_provenance.
- NP1025269.RAkUVFYjnEj4PZRKYLNX1GZlb3xEggkF2T6_tk2DeDqBM130_assertion SIO_000772 23115274 NP1025269.RAkUVFYjnEj4PZRKYLNX1GZlb3xEggkF2T6_tk2DeDqBM130_provenance.
- NP1025269.RAkUVFYjnEj4PZRKYLNX1GZlb3xEggkF2T6_tk2DeDqBM130_assertion evidence source_evidence_literature NP1025269.RAkUVFYjnEj4PZRKYLNX1GZlb3xEggkF2T6_tk2DeDqBM130_provenance.
- NP1025269.RAkUVFYjnEj4PZRKYLNX1GZlb3xEggkF2T6_tk2DeDqBM130_assertion description "[In multivariable analyses, KIT mutation (hazard ratio [HR] = 1.67; P = .04], log(10)(WBC) (HR = 1.33; P = .02), and trisomy 22 (HR = 0.54; P = .08) were relevant factors for relapse-free survival; for overall survival, FLT3 mutation (HR = 2.56; P = .006), trisomy 22 (HR = 0.45; P = .07), trisomy 8 (HR = 2.26; P = .02), age (difference of 10 years, HR = 1.46; P = .01), and therapy-related AML (HR = 2.13; P = .14) revealed as prognostic factors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1025269.RAkUVFYjnEj4PZRKYLNX1GZlb3xEggkF2T6_tk2DeDqBM130_provenance.